Table 1.
Exposure | Self-reported moderate-to-vigorous physical activity | Self-reported vigorous physical activity | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Outcomes | Method | OR | 95% CI | p-value | SNPs | Method | OR | 95% CI | p-value | SNPs |
Atrial fibrillation | IVW | 1.13 | 0.79–1.6 | 0.508 | 9 | IVW§ | 1.33 | 0.44–4.05 | 0.615 | 5 |
MR-Egger | 0.41 | 0.08–1.99 | 0.268 | 9 | MR-Egger | 0.00 | 0–13.36 | 0.177 | 5 | |
Weighted median | 1.16 | 0.72–1.86 | 0.546 | 9 | Weighted median | 1.51 | 0.51–4.48 | 0.457 | 5 | |
MR-PRESSO | 1.13 | 0.82–1.55 | 0.493 | 9 | MR-PRESSO | 1.33 | 0.44–4.05 | 0.641 | 5 | |
Coronary artery disease | IVW | 1.21 | 0.72–2.01 | 0.469 | 7†,‡ | IVW | 0.50 | 0.19–1.26 | 0.141 | 5 |
MR-Egger | 0.72 | 0.09–5.43 | 0.747 | 7†,‡ | MR-Egger | 0.55 | 0.18–1.73 | 0.308 | 5 | |
Weighted median | 1.05 | 0.55–1.99 | 0.880 | 7†,‡ | Weighted median | 0.55 | 0.18–1.73 | 0.308 | 5 | |
MR-PRESSO | 1.21 | 0.85–1.71 | 0.326 | 7†,‡ | MR-PRESSO | 0.50 | 0.27–0.9 | 0.084 | 5 | |
Myocardial infarction | IVW | 1.48 | 0.84–2.61 | 0.178 | 7†,‡ | IVW | 0.24 | 0.08–0.68 | 0.007 | 5 |
MR-Egger | 0.54 | 0–150.86 | 0.829 | 7†,‡ | MR-Egger | 0.04 | 0–271.79 | 0.467 | 5 | |
Weighted median | 0.86 | 0.15–4.85 | 0.869 | 7†,‡ | Weighted median | 0.22 | 0.06–0.78 | 0.019 | 5 | |
MR-PRESSO | 1.48 | 0.93–2.35 | 0.151 | 7†,‡ | MR-PRESSO | 0.24 | 0.12–0.47 | 0.014 | 5 | |
Heart failure | IVW | 0.89 | 0.6–1.31 | 0.543 | 9 | IVW | 1.57 | 0.71–3.45 | 0.263 | 5 |
MR-Egger | 0.47 | 0.09–2.38 | 0.360 | 9 | MR-Egger | 0.00 | 0.00–0.25 | 0.017 | 5 | |
Weighted median | 1.10 | 0.64–1.87 | 0.738 | 9 | Weighted median | 2.24 | 0.74–6.77 | 0.151 | 5 | |
MR-PRESSO | 0.89 | 0.62–1.27 | 0.532 | 9 | MR-PRESSO | 1.57 | 0.51–4.78 | 0.473 | 5 | |
Ischemic stroke | IVW | 1.14 | 0.69–1.89 | 0.606 | 8† | IVW | 0.97 | 0.36–2.65 | 0.955 | 5 |
MR-Egger | 0.61 | 0.08–4.42 | 0.622 | 8† | MR-Egger | 0.09 | 0.00–375.81 | 0.565 | 5 | |
Weighted median | 1.01 | 0.54–1.9 | 0.977 | 8† | Weighted median | 0.79 | 0.23–2.78 | 0.718 | 5 | |
MR-PRESSO | 1.14 | 0.79–1.66 | 0.509 | 8† | MR-PRESSO | 0.97 | 0.45–2.09 | 0.945 | 5 | |
Large artery stroke | IVW | 0.59 | 0.17–2.01 | 0.395 | 8† | IVW | 4.47 | 0.37–54.03 | 0.238 | 5 |
MR-Egger | 0.07 | 0–34.44 | 0.396 | 8† | MR-Egger | 32.94 | 0.00–10∧15 | 0.827 | 5 | |
Weighted median | 0.47 | 0.09–2.51 | 0.374 | 8† | Weighted median | 1.45 | 0.04–55.54 | 0.841 | 5 | |
MR-PRESSO | 0.59 | 0.12–2.79 | 0.523 | 8† | MR-PRESSO | 4.47 | 0.18–113.99 | 0.416 | 5 | |
Cardioembolic stroke | IVW | 1.68 | 0.64–4.41 | 0.289 | 8† | IVW | 1.06 | 0.16–7.05 | 0.956 | 5 |
MR-Egger | 7.30 | 0.1–531.9 | 0.363 | 8† | MR-Egger | 0.00 | 0.00–61073.42 | 0.372 | 5 | |
Weighted median | 1.97 | 0.54–7.19 | 0.303 | 8† | Weighted median | 0.53 | 0.05–5.94 | 0.605 | 5 | |
MR-PRESSO | 1.68 | 0.58–4.92 | 0.373 | 8† | MR-PRESSO | 1.06 | 0.1–10.86 | 0.966 | 5 | |
Small vessel stroke | IVW | 0.95 | 0.3–3.01 | 0.929 | 8† | IVW | 4.16 | 0.41–42.13 | 0.228 | 5 |
MR-Egger | 0.60 | 0.01–60.23 | 0.828 | 8† | MR-Egger | 0.00 | 0.00–18910.03 | 0.333 | 5 | |
Weighted median | 0.85 | 0.19–3.87 | 0.832 | 8† | Weighted median | 1.85 | 0.09–37.68 | 0.690 | 5 | |
MR-PRESSO | 0.95 | 0.32–2.82 | 0.927 | 8† | MR-PRESSO | 4.16 | 0.51–33.61 | 0.252 | 5 |
OR, odds ratio; CI confidence intervals; IVW, inverse-variance-weighted method; MR-PRESSO, MR pleiotropy residual sum and outlier method; SNPs, single-nucleotide polymorphisms.
The estimates were evaluated from a random-effects IVW method due to the presence of heterogeneity based on Cochran's Q.
rs3094622 was excluded because it was unavailable in the published GWASs and no good proxies (r2 > 0.8) were found.
rs429358 was excluded since it as associated with coronary artery disease in the PhenoScanner database.